for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Guangdong Jiaying Pharmaceutical Co Ltd

002198.SZ

Latest Trade

5.32CNY

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

3.92

 - 

6.73

As of on the Shenzhen Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
5.32
Open
--
Volume
--
3M AVG Volume
312.66
Today's High
--
Today's Low
--
52 Week High
6.73
52 Week Low
3.92
Shares Out (MIL)
507.51
Market Cap (MIL)
2,699.95
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

更多

Guangdong Jiaying Pharmaceutical Scraps Asset Acquisition Due To Changes In Market Conditions

Guangdong Jiaying Pharmaceutical Elects Chairman, Appoints General Manager

Investment management firm buys 16.01 pct stake in Guangdong Jiaying Pharmaceutical

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Guangdong Jiaying Pharmaceutical Co Ltd

GUANGDONG JIAYING PHARMACEUTICAL CO., LTD is a China-based company principally engaged in the research, development, manufacture and sales of Chinese patent medicine. The Company’s main products include Chinese traditional preparations, powders, tablets, capsules and granules, which are mainly applied in the treatment of throat disease, cold, stomach disease and others, as well as for tonic nourish purpose and others. The Company distributes its products mainly in domestic market. Through its subsidiaries, the Company is also engaged in the operation and leasing of self-owned real estate.

Industry

Major Drugs

Contact Info

Area B, Dongsheng Industrial Park

SHENZHEN, GNG

518000

China

+86.755.82808010

http://gdjyzy.com.cn/

Executive Leadership

Yong Hong Chen

Chairman of the Board

Xiaoyan Chen

Chief Financial Officer

Li Bing Huang

General Manager, Director

Kangmin Huang

Secretary of the Board, Deputy General Manager

Jun Min Huang

Director

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
5.21
Price To Book (MRQ)
4.07
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
11.31
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
-18.60
Return on Equity (TTM)
-15.85

Latest News

Latest News

焦点:中国A股熊市令大股东资金饥渴难熬 上市公司壳交易升温

今年以来中国A股市场熊市特征明显,在不少上市公司大股东增持为股价“打气”的同时,亦有一些大股东已扛不住,被迫转让上市公司控股权,令近期国内壳交易开始升温,壳概念个股走势坚挺。业内人士预计,若政策面没有变化,未来壳交易还会继续热络出现。

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up